313 related articles for article (PubMed ID: 31881776)
21. Brazilian guidelines on hematopoietic stem cell transplantation in acute myeloid leukemia.
Silla L; Dulley F; Saboya R; Kerbauy F; de Moraes Arantes A; Pezzi A; Gross LG; Paton E; Hamerschlak N
Eur J Haematol; 2017 Feb; 98(2):177-183. PubMed ID: 27621140
[TBL] [Abstract][Full Text] [Related]
22. Extramedullary Relapse of Acute Myelogenous Leukemia after Allogeneic Hematopoietic Stem Cell Transplantation.
Yuda S; Fuji S; Onishi A; Tanaka T; Inamoto Y; Kurosawa S; Kim SW; Fukuda T
Biol Blood Marrow Transplant; 2019 Jun; 25(6):1152-1157. PubMed ID: 30660773
[TBL] [Abstract][Full Text] [Related]
23. Graft Engineering and Adoptive Immunotherapy: New Approaches to Promote Immune Tolerance After Hematopoietic Stem Cell Transplantation.
Bertaina A; Roncarolo MG
Front Immunol; 2019; 10():1342. PubMed ID: 31354695
[TBL] [Abstract][Full Text] [Related]
24. Incubation of Immune Cell Grafts With MAX.16H5 IgG1 Anti-Human CD4 Antibody Prolonged Survival After Hematopoietic Stem Cell Transplantation in a Mouse Model for Fms Like Tyrosine Kinase 3 Positive Acute Myeloid Leukemia.
Hilger N; Mueller C; Stahl L; Mueller AM; Zoennchen B; Dluczek S; Halbich C; Wickenhauser C; Gerloff D; Wurm AA; Behre G; Kretschmer A; Fricke S
Front Immunol; 2018; 9():2408. PubMed ID: 30405611
[TBL] [Abstract][Full Text] [Related]
25. Current and emerging therapies for acute myeloid leukemia.
Robak T; Wierzbowska A
Clin Ther; 2009; 31 Pt 2():2349-70. PubMed ID: 20110045
[TBL] [Abstract][Full Text] [Related]
26. Biology-Driven Approaches to Prevent and Treat Relapse of Myeloid Neoplasia after Allogeneic Hematopoietic Stem Cell Transplantation.
Zeiser R; Beelen DW; Bethge W; Bornhäuser M; Bug G; Burchert A; Christopeit M; Duyster J; Finke J; Gerbitz A; Klusmann JH; Kobbe G; Lübbert M; Müller-Tidow C; Platzbecker U; Rösler W; Sauer M; Schmid C; Schroeder T; Stelljes M; Kröger N; Müller LP
Biol Blood Marrow Transplant; 2019 Apr; 25(4):e128-e140. PubMed ID: 30658222
[TBL] [Abstract][Full Text] [Related]
27. [Allogeneic stem cell transplantation for 75 cases of acute myeloid leukemia in complete remission: outcome and prognostic analysis].
Song AX; Yang DL; Wei JL; Yan ZS; Wang M; Jiang EL; Huang Y; Liu QG; Ma QL; Zhai WH; Zhang RL; Feng SZ; Han MZ
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2010 Feb; 18(1):161-6. PubMed ID: 20137139
[TBL] [Abstract][Full Text] [Related]
28. [Clinical Analysis for Patients with AML Treated after Allo-HSCT].
Wang QY; Dong YJ; Liang ZY; Yin Y; Liu W; Xu WL; Sun YH; Han N; Li Y; Ren HY
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2020 Aug; 28(4):1105-1114. PubMed ID: 32798384
[TBL] [Abstract][Full Text] [Related]
29. Novel therapeutic options in Acute Myeloid Leukemia.
Medinger M; Lengerke C; Passweg J
Leuk Res Rep; 2016; 6():39-49. PubMed ID: 27752467
[TBL] [Abstract][Full Text] [Related]
30. Allogeneic Hematopoietic Stem Cell Transplantation in FLT3-ITD-Positive Acute Myelogenous Leukemia: The Role for FLT3 Tyrosine Kinase Inhibitors Post-Transplantation.
Schiller GJ; Tuttle P; Desai P
Biol Blood Marrow Transplant; 2016 Jun; 22(6):982-990. PubMed ID: 26785334
[TBL] [Abstract][Full Text] [Related]
31. [Allogeneic hematopoietic stem cell transplantation for the treatment of acute myeloid leukemia with primary thrombocytosis: three cases report and literatures review].
Zong XP; Tang L; Cen JN; Chen SN; Sun AN; Wu DP
Zhonghua Xue Ye Xue Za Zhi; 2017 Oct; 38(10):883-886. PubMed ID: 29166742
[No Abstract] [Full Text] [Related]
32. [Allogenic transplantation of hematopoietic stem cells in the treatment of children with high-risk acute leukemia].
Starý J; Kobylka P; Sedlácek P; Komrska V; Vávra V; Syrůcková Z; Smísek P; Hrubá A; Korínková P; Matĕjková E; Cukrová V; Dolezalová L; Loudová M; Sejkorová J; Kvĕch J
Cas Lek Cesk; 1998 Jun; 137(12):363-7. PubMed ID: 9721472
[TBL] [Abstract][Full Text] [Related]
33. [Sorafenib combined with chemotherapy and donor lymphocyte infusion as salvage therapy in patients with FLT3-positive acute myeloid leukemia relapse after allogeneic hematopoietic stem cell transplantation].
Xuan L; Fan ZP; Zhang Y; Xu N; Ye JY; Zhou X; Wang ZX; Sun J; Liu QF; Huang F
Zhonghua Nei Ke Za Zhi; 2018 May; 57(5):351-354. PubMed ID: 29747291
[TBL] [Abstract][Full Text] [Related]
34. Interferon-α Is Effective for Treatment of Minimal Residual Disease in Patients with t(8;21) Acute Myeloid Leukemia After Allogeneic Hematopoietic Stem Cell Transplantation: Results of a Prospective Registry Study.
Mo XD; Wang Y; Zhang XH; Xu LP; Yan CH; Chen H; Chen YH; Qin YZ; Liu KY; Huang XJ
Oncologist; 2018 Nov; 23(11):1349-1357. PubMed ID: 30076280
[TBL] [Abstract][Full Text] [Related]
35. Clinical impact of colonization with multidrug-resistant organisms on outcome after allogeneic stem cell transplantation in patients with acute myeloid leukemia.
Scheich S; Lindner S; Koenig R; Reinheimer C; Wichelhaus TA; Hogardt M; Besier S; Kempf VAJ; Kessel J; Martin H; Wilke AC; Serve H; Bug G; Steffen B
Cancer; 2018 Jan; 124(2):286-296. PubMed ID: 28960264
[TBL] [Abstract][Full Text] [Related]
36. Which Acute Myeloid Leukemia Patients Should Be Offered Transplantation?
Brissot E; Mohty M
Semin Hematol; 2015 Jul; 52(3):223-31. PubMed ID: 26111470
[TBL] [Abstract][Full Text] [Related]
37. [HLA-10/10 matched unrelated donor versus sibling donor hematopoietic stem cell transplantation for adult acute myeloid leukemia].
Yao JF; Zhang GX; Shen YY; Zhang RL; He Y; Wei JL; Jiang EL; Yang DL; Feng SZ; Han MZ
Zhonghua Xue Ye Xue Za Zhi; 2019 Jun; 40(6):460-466. PubMed ID: 31340617
[No Abstract] [Full Text] [Related]
38. [Effects of pre-transplant course on prognosis of allogeneic hematopoietic stem cell transplantation in patients with acute myeloid leukemia].
Liu XJ; Huang XJ; Xu LP; Liu KY; Zhang XH; Yan CH; Wang Y
Zhonghua Xue Ye Xue Za Zhi; 2019 Mar; 40(3):182-186. PubMed ID: 30929382
[No Abstract] [Full Text] [Related]
39. Poor outcome with nonmyeloablative conditioning regimen before cord blood transplantation for patients with high-risk acute myeloid leukemia compared with matched related or unrelated donor transplantation.
Devillier R; Harbi S; Fürst S; Crocchiolo R; El-Cheikh J; Castagna L; Etienne A; Calmels B; Lemarie C; Prebet T; Granata A; Charbonnier A; Rey J; Chabannon C; Faucher C; Vey N; Blaise D
Biol Blood Marrow Transplant; 2014 Oct; 20(10):1560-5. PubMed ID: 24933658
[TBL] [Abstract][Full Text] [Related]
40. Response to Novel Drugs before and after Allogeneic Stem Cell Transplantation in Patients with Relapsed Multiple Myeloma.
López-Corral L; Caballero-Velázquez T; López-Godino O; Rosiñol L; Pérez-Vicente S; Fernandez-Avilés F; Krsnik I; Morillo D; Heras I; Morgades M; Rifon JJ; Sampol A; Iniesta F; Ocio EM; Martin J; Rovira M; Cabero M; Castilla-Llorente C; Ribera JM; Torres-Juan M; Moraleda JM; Martinez C; Vázquez A; Gutierrez G; Caballero D; San Miguel JF; Mateos MV; Pérez-Simón JA
Biol Blood Marrow Transplant; 2019 Sep; 25(9):1703-1712. PubMed ID: 31054983
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
